698 related articles for article (PubMed ID: 15671251)
41. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer.
Hafner C; Becker B; Landthaler M; Vogt T
Mod Pathol; 2006 Oct; 19(10):1369-77. PubMed ID: 16862074
[TBL] [Abstract][Full Text] [Related]
42. Effect of EPH-ephrin signaling on the growth of human leukemia cells.
Takahashi Y; Itoh M; Nara N; Tohda S
Anticancer Res; 2014 Jun; 34(6):2913-8. PubMed ID: 24922654
[TBL] [Abstract][Full Text] [Related]
43. Activation of ephrin A proteins influences hematopoietic stem cell adhesion and trafficking patterns.
Ting MJ; Day BW; Spanevello MD; Boyd AW
Exp Hematol; 2010 Nov; 38(11):1087-98. PubMed ID: 20655977
[TBL] [Abstract][Full Text] [Related]
44. Interaction between ephrins/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of neuronal degeneration.
Calò L; Cinque C; Patanè M; Schillaci D; Battaglia G; Melchiorri D; Nicoletti F; Bruno V
J Neurochem; 2006 Jul; 98(1):1-10. PubMed ID: 16805791
[TBL] [Abstract][Full Text] [Related]
45. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O.
Shintani T; Ihara M; Sakuta H; Takahashi H; Watakabe I; Noda M
Nat Neurosci; 2006 Jun; 9(6):761-9. PubMed ID: 16680165
[TBL] [Abstract][Full Text] [Related]
46. Eph receptors and zonation in the rat adrenal cortex.
Brennan CH; Chittka A; Barker S; Vinson GP
J Endocrinol; 2008 Jul; 198(1):185-91. PubMed ID: 18463147
[TBL] [Abstract][Full Text] [Related]
47. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells.
Sakamoto A; Sugamoto Y; Tokunaga Y; Yoshimuta T; Hayashi K; Konno T; Kawashiri MA; Takeda Y; Yamagishi M
J Int Med Res; 2011; 39(2):522-7. PubMed ID: 21672356
[TBL] [Abstract][Full Text] [Related]
48. Ephrins negatively regulate cell proliferation in the epidermis and hair follicle.
Genander M; Holmberg J; Frisén J
Stem Cells; 2010 Jul; 28(7):1196-205. PubMed ID: 20506314
[TBL] [Abstract][Full Text] [Related]
49. Ephrin-A4 inhibits sensory neurite outgrowth and is regulated by neonatal skin wounding.
Moss A; Alvares D; Meredith-Middleton J; Robinson M; Slater R; Hunt SP; Fitzgerald M
Eur J Neurosci; 2005 Nov; 22(10):2413-21. PubMed ID: 16307584
[TBL] [Abstract][Full Text] [Related]
50. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
[TBL] [Abstract][Full Text] [Related]
51. Ephrin/ephrin receptor expression during early stages of mouse inner ear development.
Saeger BM; Suhm M; Neubüser A
Dev Dyn; 2011 Jun; 240(6):1578-85. PubMed ID: 21465626
[TBL] [Abstract][Full Text] [Related]
52. Eph/ephrin expression in the adult rat visual system following localized retinal lesions: localized and transneuronal up-regulation in the retina and superior colliculus.
Rodger J; Symonds AC; Springbett J; Shen WY; Bartlett CA; Rakoczy PE; Beazley LD; Dunlop SA
Eur J Neurosci; 2005 Oct; 22(8):1840-52. PubMed ID: 16262624
[TBL] [Abstract][Full Text] [Related]
53. Eph receptors inactivate R-Ras through different mechanisms to achieve cell repulsion.
Dail M; Richter M; Godement P; Pasquale EB
J Cell Sci; 2006 Apr; 119(Pt 7):1244-54. PubMed ID: 16522685
[TBL] [Abstract][Full Text] [Related]
54. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains.
Marquardt T; Shirasaki R; Ghosh S; Andrews SE; Carter N; Hunter T; Pfaff SL
Cell; 2005 Apr; 121(1):127-39. PubMed ID: 15820684
[TBL] [Abstract][Full Text] [Related]
55. A new ephrin-A1 isoform (ephrin-A1b) with altered receptor binding properties abrogates the cleavage of ephrin-A1a.
Finne EF; Munthe E; Aasheim HC
Biochem J; 2004 Apr; 379(Pt 1):39-46. PubMed ID: 14692877
[TBL] [Abstract][Full Text] [Related]
56. Cloning, chromosal mapping, and tissue expression of the gene encoding the human Eph-family kinase ligand ephrin-A2.
Aasheim HC; Pedeutour F; Grosgeorge J; Logtenberg T
Biochem Biophys Res Commun; 1998 Nov; 252(2):378-82. PubMed ID: 9826538
[TBL] [Abstract][Full Text] [Related]
57. EphA/ephrin-A interactions during optic nerve regeneration: restoration of topography and regulation of ephrin-A2 expression.
Rodger J; Vitale PN; Tee LB; King CE; Bartlett CA; Fall A; Brennan C; O'Shea JE; Dunlop SA; Beazley LD
Mol Cell Neurosci; 2004 Jan; 25(1):56-68. PubMed ID: 14962740
[TBL] [Abstract][Full Text] [Related]
58. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
Liu DP; Wang Y; Koeffler HP; Xie D
Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
[TBL] [Abstract][Full Text] [Related]
59. Ephrins and their receptors: binding versus biology.
Blits-Huizinga CT; Nelersa CM; Malhotra A; Liebl DJ
IUBMB Life; 2004 May; 56(5):257-65. PubMed ID: 15370889
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of retinal neovascularization by soluble EphA2 receptor.
Chen J; Hicks D; Brantley-Sieders D; Cheng N; McCollum GW; Qi-Werdich X; Penn J
Exp Eye Res; 2006 Apr; 82(4):664-73. PubMed ID: 16359662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
